← Open Payments lookup

SAMI PHUYAL: Open Payments

NPI 1760157598 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$300 in 15 payments from 10 companies in 2025. Trend: 2023 $141 · 2024 $47 · 2025 $300

Food & beverage: $300
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$67
Alkermes, Inc.2$50
ABBVIE INC.2$34
Otsuka America Pharmaceutical, Inc.2$33
E.R. Squibb & Sons, L.L.C.1$29
Vanda Pharmaceuticals Inc.1$23
Janssen Pharmaceuticals, Inc1$18
Corium, LLC1$18
Lundbeck LLC1$15
Collegium Pharmaceutical, Inc.1$15

Products named: CAPLYTA, ARISTADA, REXULTI, VRAYLAR, COBENFY, FANAPT, INVEGA SUSTENNA, Azstarys.

Industry payments across ID — which companies pay providers there.